Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
June 2, 2022 -- A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept– drugs widely used to treat certain autoimmune...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Abatacept | Clinical Trials | COVID-19 | National Institutes of Health (NIH) | Orencia | Pharmaceuticals | Remicade